Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  SenzaGen AB    SENZA   SE0010219626

SENZAGEN AB

(SENZA)
  Report
End-of-day quote. End-of-day quote NASDAQ OMX STOCKHOLM - 10/22
20.5 SEK   -0.49%
09/16SENZAGEN : Global medical device company places SEK 0.6 million order
AQ
09/11SENZAGEN : receives order for GARD™skin and GARD™potency from a major US chemical company
AQ
 SummaryChartsNewsCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq Omx Stockholm
10/16/2020 10/19/2020 10/20/2020 10/21/2020 10/22/2020 Date
21.5 21.1 21.7 20.6 20.5 Last
13504 13648 12898 10460 7137 Volume
+1.90% -1.86% +2.84% -5.07% -0.49% Change
Financials
Sales 2018 9,53 M 1,09 M 1,09 M
Net income 2018 -16,1 M -1,83 M -1,83 M
Net cash position 2018 56,6 M 6,45 M 6,45 M
P/E ratio 2018 -31,2x
Yield 2018 -
Sales 2019 4,92 M 0,56 M 0,56 M
Net income 2019 -50,2 M -5,72 M -5,72 M
Net cash position 2019 120 M 13,7 M 13,7 M
P/E ratio 2019 -6,00x
Yield 2019 -
Capitalization 438 M 50,0 M 49,9 M
EV / Sales 2018 47,0x
EV / Sales 2019 56,6x
Nbr of Employees 17
Free-Float 84,2%
More Financials
Company
SenzaGen AB is a Sweden-based company, which specializes in immunology, technology and genomics. The Company markets, sells and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its own laboratory and through licensed Contract Research Organization (CROs). SenzaGen AB makes it possible to replace animal experiments with in vitro genetic testing to determine the allergenicity of... 
More about the company
All news about SENZAGEN AB
09/16SENZAGEN : Global medical device company places SEK 0.6 million order
AQ
09/11SENZAGEN : receives order for GARD™skin and GARD™potency from a majo..
AQ
More news
News in other languages on SENZAGEN AB

- No features available -

More news
Chart SENZAGEN AB
Duration : Period :
SenzaGen AB Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Axel Sjöblad Chief Executive Officer
Karl Arne Krister Borrebaeck Chairman
Marianne Olsson Chief Financial Officer
Gunilla Grundström Chief Scientific Officer
Ann Ulrika Gidner Director
Sector and Competitors
1st jan.Capitalization (M$)
SENZAGEN AB9.86%50
EXACT SCIENCES CORPORATION15.80%14 958
GUARDANT HEALTH, INC.31.42%9 958
BGI GENOMICS CO., LTD.100.82%8 452
ADAPTIVE BIOTECHNOLOGIES CORPORATION56.85%6 375
SEEGENE INC--.--%6 306